Prise en charge des métastases hépatiques synchrones d'origine colorectale

Hill, 2006, The frequency of cancer in France in year 2002, and trends since 1968, Bull Cancer, 93, 7 Hill, 2007, The frequency of cancer in France: all ages and under age 15, mortality in 2003 and trends since 1968, Bull Cancer, 94, 7 Jemal, 2007, Cancer statistics, 2007, CA Cancer J Clin, 57, 43, 10.3322/canjclin.57.1.43 Bruinvels, 1994, Follow-up of patients with colorectal cancer. A meta-analysis, Ann Surg, 219, 174, 10.1097/00000658-199402000-00009 Fong, 1999, Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases, Ann Surg, 230, 309, 10.1097/00000658-199909000-00004 Morris, 2010, Surgical management and outcomes of colorectal cancer liver metastases, Br J Surg, 97, 1110, 10.1002/bjs.7032 Geoghegan, 1999, Treatment of colorectal liver metastases, Br J Surg, 86, 158, 10.1046/j.1365-2168.1999.01013.x Zoratto, 2012, Critical appraisal of bevacizumab in the treatment of metastatic colorectal cancer, Onco Targets Ther, 5, 199 Lehmann, 2011, Chemotherapy before liver resection of colorectal metastases: friend or foe?, Ann Surg, 255, 237, 10.1097/SLA.0b013e3182356236 Nordlinger, 2008, Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial, Lancet, 371, 1007, 10.1016/S0140-6736(08)60455-9 Nordlinger, 2012, EORTC liver metastases intergroup randomized phase III study 40983: long-term survival results. ASCO Annual Meeting Proceedings, J Clin Oncol, 30, 10.1200/jco.2012.30.15_suppl.3508 Adam, 2010, Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases?, Ann Surg, 252, 774, 10.1097/SLA.0b013e3181fcf3e3 Reddy, 2009, Timing of multimodality therapy for resectable synchronous colorectal liver metastases: a retrospective multi-institutional analysis, Ann Surg Oncol, 16, 1809, 10.1245/s10434-008-0181-y Adam, 2004, Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?, Ann Surg, 240, 1052, 10.1097/01.sla.0000145964.08365.01 Blazer, 2008, Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases, J Clin Oncol, 26, 5344, 10.1200/JCO.2008.17.5299 Allen, 2003, Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases, J Gastrointest Surg, 7, 109, 10.1016/S1091-255X(02)00121-X Vigano, 2012, Progression while receiving preoperative chemotherapy should not be an absolute contraindication to liver resection for colorectal metastases, Ann Surg Oncol, 19, 2786, 10.1245/s10434-012-2382-7 Adam, 2007, Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy, J Clin Oncol, 25, 4593, 10.1200/JCO.2007.10.8126 Boige, 2008, Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure, Ann Surg Oncol, 15, 219, 10.1245/s10434-007-9581-7 Fujita, 2000, Resection of synchronous liver metastases from colorectal cancer, Jpn J Clin Oncol, 30, 7, 10.1093/jjco/hyd002 Jaeck, 1996, Surgical treatment of synchronous hepatic metastases of colorectal cancers. Simultaneous or delayed resection?, Ann Chir, 50, 507 Jenkins, 1997, Hepatic resection for metastatic colorectal cancer, Am Surg, 63, 605 Nordlinger, 1996, Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie, Cancer, 77, 1254, 10.1002/(SICI)1097-0142(19960401)77:7<1254::AID-CNCR5>3.0.CO;2-I Chua, 2004, Concurrent vs staged colectomy and hepatectomy for primary colorectal cancer with synchronous hepatic metastases, Dis Colon Rectum, 47, 1310, 10.1007/s10350-004-0586-z Lyass, 2001, Combined colon and hepatic resection for synchronous colorectal liver metastases, J Surg Oncol, 78, 17, 10.1002/jso.1117 Martin, 2009, Simultaneous versus staged resection for synchronous colorectal cancer liver metastases, J Am Coll Surg, 208, 842, 10.1016/j.jamcollsurg.2009.01.031 Stella, 2012, A comparative study of patients with and without associated digestive surgery in a two-stage hepatectomy setting, Langenbecks Arch Surg, 397, 1289, 10.1007/s00423-012-1002-0 Capussotti, 2007, Major liver resections synchronous with colorectal surgery, Ann Surg Oncol, 14, 195, 10.1245/s10434-006-9055-3 Hillingso, 2009, Staged or simultaneous resection of synchronous liver metastases from colorectal cancer-a systematic review, Colorectal Dis, 11, 3, 10.1111/j.1463-1318.2008.01625.x Reddy, 2007, Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis, Ann Surg Oncol, 14, 3481, 10.1245/s10434-007-9522-5 Mentha, 2006, Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary, Br J Surg, 93, 872, 10.1002/bjs.5346 Andres, 2012, A survival analysis of the liver-first reversed management of advanced simultaneous colorectal liver metastases: a livermetsurvey-based study, Ann Surg, 256, 772, 10.1097/SLA.0b013e3182734423 Kapiteijn, 2001, Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer, N Engl J Med, 345, 638, 10.1056/NEJMoa010580 Sauer, 2004, Preoperative versus postoperative chemoradiotherapy for rectal cancer, N Engl J Med, 351, 1731, 10.1056/NEJMoa040694 de Campos-Lobato, 2011, Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence, Ann Surg Oncol, 18, 1590, 10.1245/s10434-010-1506-1 Garcia-Aguilar, 2011, Optimal timing of surgery after chemoradiation for advanced rectal cancer: preliminary results of a multicenter, nonrandomized phase II prospective trial, Ann Surg, 254, 97, 10.1097/SLA.0b013e3182196e1f Smith, 2010, Clinical significance of acellular mucin in rectal adenocarcinoma patients with a pathologic complete response to preoperative chemoradiation, Ann Surg, 251, 261, 10.1097/SLA.0b013e3181bdfc27 Sauer, 2012, Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years, J Clin Oncol, 30, 1926, 10.1200/JCO.2011.40.1836 Aschele, 2011, Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial, J Clin Oncol, 29, 2773, 10.1200/JCO.2010.34.4911 Gerard, 2010, Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2, J Clin Oncol, 28, 1638, 10.1200/JCO.2009.25.8376 Ngan, 2012, Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with t3 rectal cancer: trans-tasman Radiation Oncology Group Trial 01.04, J Clin Oncol, 30, 3827, 10.1200/JCO.2012.42.9597 Rouanet P (responsable). A randomized multicenter phase 2 study: a tailored strategy for locally advanced rectal carcinoma- www.ClinicalTrial.gov Identifier : NCT01333709. van Ooijen, 1992, Hepatic resections for colorectal metastases in The Netherlands. A multiinstitutional 10-year study, Cancer, 70, 28, 10.1002/1097-0142(19920701)70:1<28::AID-CNCR2820700105>3.0.CO;2-9 Fortner, 1984, Multivariate analysis of a personal series of 247 patients with liver metastases from colorectal cancer. II. Treatment by intrahepatic chemotherapy, Ann Surg, 199, 317, 10.1097/00000658-198403000-00011 Folprecht, 2010, Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial, Lancet Oncol, 11, 38, 10.1016/S1470-2045(09)70330-4 Folprecht, 2005, Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates, Ann Oncol, 16, 1311, 10.1093/annonc/mdi246 Bismuth, 1996, Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy, Ann Surg, 224, 509, 10.1097/00000658-199610000-00009 Adam, 2001, Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal, Ann Surg Oncol, 8, 347, 10.1007/s10434-001-0347-3 Power, 2011, Chemotherapy for the conversion of unresectable colorectal cancer liver metastases to resection, Crit Rev Oncol Hematol, 79, 251, 10.1016/j.critrevonc.2010.08.001 Falcone, 2007, J Clin Oncol, 25, 1670, 10.1200/JCO.2006.09.0928 Masi, 2010, Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial, Lancet Oncol, 11, 845, 10.1016/S1470-2045(10)70175-3 Goere, 2010, Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases, Ann Surg, 251, 686, 10.1097/SLA.0b013e3181d35983 Rubbia-Brandt, 2010, Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis, Histopathology, 56, 430, 10.1111/j.1365-2559.2010.03511.x Vauthey, 2006, Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases, J Clin Oncol, 24, 2065, 10.1200/JCO.2005.05.3074 Robinson, 2012, Chemotherapy-associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis, Ann Surg Oncol, 10.1245/s10434-012-2438-8 Chua, 2010, Systematic review of randomized and nonrandomized trials of the clinical response and outcomes of neoadjuvant systemic chemotherapy for resectable colorectal liver metastases, Ann Surg Oncol, 17, 492, 10.1245/s10434-009-0781-1 Benoist, 2006, Complete response of colorectal liver metastases after chemotherapy: does it mean cure?, J Clin Oncol, 24, 3939, 10.1200/JCO.2006.05.8727 Elias, 2007, Outcome of posthepatectomy-missing colorectal liver metastases after complete response to chemotherapy: impact of adjuvant intra-arterial hepatic oxaliplatin, Ann Surg Oncol, 14, 3188, 10.1245/s10434-007-9482-9 Ferrero, 2012, Intraoperative detection of disappearing colorectal liver metastases as a predictor of residual disease, J Gastrointest Surg, 16, 806, 10.1007/s11605-011-1810-5 Tanaka, 2009, Importance of complete pathologic response to prehepatectomy chemotherapy in treating colorectal cancer metastases, Ann Surg, 250, 935, 10.1097/SLA.0b013e3181b0c6e4 Gaujoux, 2011, Complete radiological response of colorectal liver metastases after chemotherapy: what can we expect?, Dig Surg, 28, 114, 10.1159/000323820 Torzilli, 2005, Contrast-enhanced intraoperative ultrasonography during hepatectomies for colorectal cancer liver metastases, J Gastrointest Surg, 9, 1148, 10.1016/j.gassur.2005.08.016 Timmerman, 2009, Local surgical, ablative, and radiation treatment of metastases, CA Cancer J Clin, 59, 145, 10.3322/caac.20013 Weng, 2012, Radiofrequency ablation versus resection for colorectal cancer liver metastases: a meta-analysis, PLoS One, 7, e45493, 10.1371/journal.pone.0045493 Evrard, 2012, Unresectable colorectal cancer liver metastases treated by intraoperative radiofrequency ablation with or without resection, Br J Surg, 99, 558, 10.1002/bjs.8665 Ruers, 2010, Final results of the EORTC intergroup randomized study 40004 (CLOCC) evaluating the benefit of radiofrequency ablation (RFA) combined with chemotherapy for unresectable colorectal liver metastases (CRC LM). ASCO Annual Meeting Proceedings, J Clin Oncol, 28, 10.1200/jco.2010.28.15_suppl.3526 Adam, 2000, Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors, Ann Surg, 232, 777, 10.1097/00000658-200012000-00006 Karoui, 2010, Combined first-stage hepatectomy and colorectal resection in a two-stage hepatectomy strategy for bilobar synchronous liver metastases, Br J Surg, 97, 1354, 10.1002/bjs.7128 Chua, 2012, Summary outcomes of two-stage resection for advanced colorectal liver metastases, J Surg Oncol Schnitzbauer, 2012, Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings, Ann Surg, 255, 405, 10.1097/SLA.0b013e31824856f5 Scheer, 2008, Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases, Ann Oncol, 19, 1829, 10.1093/annonc/mdn398 Tan, 2012, Systematic review and meta-analysis of randomized clinical trials of self-expanding metallic stents as a bridge to surgery versus emergency surgery for malignant left-sided large bowel obstruction, Br J Surg, 99, 469, 10.1002/bjs.8689 Fernandez-Esparrach, 2010, Severe complications limit long-term clinical success of self-expanding metal stents in patients with obstructive colorectal cancer, Am J Gastroenterol, 105, 1087, 10.1038/ajg.2009.660 Gianotti, 2012, A prospective evaluation of short-term and long-term results from colonic stenting for palliation or as a bridge to elective operation versus immediate surgery for large-bowel obstruction, Surg Endosc Chau, 2006, Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer, J Clin Oncol, 24, 668, 10.1200/JCO.2005.04.4875 Vigano, 2012, Treatment strategy for colorectal cancer with resectable synchronous liver metastases: is any evidence-based strategy possible?, World J Hepatol, 4, 237, 10.4254/wjh.v4.i8.237 Verhoef, 2011, Surgery of the primary in stage IV colorectal cancer with unresectable metastases, Eur J Cancer, 47, S61, 10.1016/S0959-8049(11)70148-4 Galfrascoli, 2011, Risk/benefit profile of bevacizumab in metastatic colon cancer: a systematic review and meta-analysis, Dig Liver Dis, 43, 286, 10.1016/j.dld.2010.10.010 Bose, 2010, Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care, Lancet Oncol, 11, 373, 10.1016/S1470-2045(09)70341-9 Scheer, 2008, Increased metabolic activity of indolent liver metastases after resection of a primary colorectal tumor, J Nucl Med, 49, 887, 10.2967/jnumed.107.048371 Karoui, 2011, Primary colectomy in patients with stage IV colon cancer and unresectable distant metastases improves overall survival: results of a multicentric study, Dis Colon Rectum, 54, 930, 10.1097/DCR.0b013e31821cced0 Stillwell, 2010, Meta-analysis of survival of patients with stage IV colorectal cancer managed with surgical resection versus chemotherapy alone, World J Surg, 34, 797, 10.1007/s00268-009-0366-y Cirocchi, 2012, Non-resection versus resection for an asymptomatic primary tumour in patients with unresectable stage IV colorectal cancer, Cochrane Database Syst Rev, 8, CD008997